MINERAL WELLS, Texas (PRWEB) September 24, 2020
Electromedical Products International, Inc. (EPI) has named Andrew J. Miclot as President to accelerate the company’s mission to provide fast, safe, and effective, non-pharmaceutical treatment to people suffering from anxiety, insomnia, depression, and pain using EPI’s Alpha-Stim® handheld brain stimulation device.
Founder Dr. Daniel L. Kirsch established EPI in 1981. He and his wife, Tracey B. Kirsch have shepherded the company to success, including more than 100 clinical studies citing the effectiveness of Alpha-Stim technology. Both Dr. Kirsch and Mrs. Kirsch will remain on the Board of the Directors as Mr. Miclot transitions into the President role. Tracey B. Kirsch will become EPI’s Chief Executive Officer.
“We are delighted to bring someone of Andrew’s caliber to lead EPI at a time when Covid-19 is affecting so many people who could benefit from using the Alpha-Stim,” said Mrs. Kirsch. “His past successes enhancing shareholder value and his mentoring leadership style will help accelerate our mission to help patients and provide an excellent work environment for our team here in Texas and distribution network worldwide.”
Dr. Daniel L. Kirsch, who is a board-certified pain specialist by the American Academy of Pain Management, commented, “It’s difficult to hand over the keys to someone when the vehicle represents your life’s work, and we will remain engaged in the company during the transition. We look forward to welcoming Andrew and his wife to Mineral Wells and the EPI family. We anticipate continued success under his leadership.”
“My goal is to continue the path that the Kirsch’s have so clearly laid out and work with the EPI team to amplify the message that there IS a clear choice for people dealing with anxiety, insomnia, depression, and pain that is drug-free, safe, and amazingly affordable,” remarked Miclot. “The fact that Alpha-Stim is broadly used today by the Veterans Administration (VA) and Department of Defense (DoD) to help veterans and Service Members gives us great pride and we hope to help many more people in the near future.”
Andrew Miclot has had success in growing a wide range of medical device companies, ranging from early stage to Fortune 500 medical device companies. His business insight, transformational leadership, and strategic vision have repeatedly led to unprecedented gains in global market share, revenue, and profitability. Most recently, he was Vice Chairman and President of WishBone Medical.
Other high-level leadership experience include successful President and CEO roles at Ascension Orthopedics and Micro Machine Co. Mr. Miclot was General Manager, Senior Vice President, and Officer of ArthroCare Corporation’s $100 million ENT division, where he successfully delivered 3 consecutive years of double-digit growth after several years of flat sales.
From 1994 to 2007, Mr. Miclot served as Senior Vice President, Officer, and IRO with Symmetry Medical, leading the company from a $10 million, breakeven medical device company to annual revenue in excess of $300 million, $51 million profit, and an IPO. He spearheaded the acquisition of 5 global companies totaling $105 million and led diversification into 25 new medical markets, by leading the development of more than 500 products (57 of which were patented).
Mr. Miclot has served on several Boards including WishBone Medical which helps children suffering from orthopedic issues and Cardinal Services which works to empower people with disabilities. Currently, he is on the Indiana University College Alumni Board with a focus on helping students with career achievement and on the Precision Optics Board that manufactures optical imaging systems for minimally invasive surgical procedures.
He has a BA in Speech and Hearing Sciences and an MA in Audiology from Indiana University and an MBA from Lake Forest Graduate School of Management.
Alpha-Stim® is a non-invasive prescription medical device (prescription not required outside the U.S.) that is FDA cleared to provide fast, safe and effective treatment of anxiety, insomnia, depression, and pain. The brain functions electrochemically and can be readily modified by electrical intervention. The Alpha-Stim AID utilizes cranial electrotherapy stimulation (CES) to deliver the only patented waveform which is clinically proven to significantly decrease anxiety and comorbid depression. The Alpha-Stim M uses CES to treat mood and sleep, plus microcurrent electrical therapy (MET) to also treat pain. Alpha-Stim can be used alone, along with other therapies, or as an adjunct to medication (without the risk of drug interactions). There are no serious adverse effects, no risk of addiction, and more than 100 research studies over 35 years that prove the effectiveness of this low level electrical prescription brain therapy. To learn more, call 1-800-FOR-PAIN or visit http://www.alpha-stim.com.
Full disclosure of the minor and self-limiting risks at http://www.alpha-stim.com/risk.
EPI is a medical device company that designs, manufactures and markets cranial electrotherapy stimulation and microcurrent electrical therapy prescription medical devices. Their products have utility patents in the U.S., China and Europe and are cleared by the FDA for use in medical facilities, physician offices and at home in the U.S. It has been on the Federal Supply Schedule in the US since 2005. It requires medical prescription in US but is sold over the counter worldwide. Covid-19 has increased demand for the Alpha-Stim as people worldwide are seeking non-drug treatment for anxiety, insomnia, depression and pain.